• 1
    Messaad D, Sahla H, Benhamed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004;140:10011006.
  • 2
    Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177180.
  • 3
    Quiralte J, Blanco C, Delgado J, Ortega  , Alcantara M, Castillo R et al. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J Investig Allergol Clin Immunol 2007;3:182188.
  • 4
    Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854863.
  • 5
    Demoly P, Kropf R, Bircher A, Pichler W. Drug hypersensitivity: questionnaire. Allergy 1999;54:9991003.
  • 6
    Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391397.
  • 7
    Demoly P, Romano A, Botelho C, Bousquet-Rouanet L, Gaeta F, Silva R et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy 2010;65:327332.
  • 8
    Waton J, Pouget-Jasson C, Loos-Ayav C, Trechot P, Bursztejn AC, Schmutz JL et al. Drug re-challenges in cutaneous adverse drug reactions: information and effectiveness in the long-term management of patients. Allergy 2011;66:941947.